Showing 9591-9600 of 20328 results for "".
- Fecal Microbiota Transplant Did Not Improve MDRO Decolonizationhttps://reachmd.com/news/fecal-microbiota-transplant-mdro-decolonization/2486885/Key Takeaways No significant difference in 4-week MDRO decolonization was observed between FMT and sham. Reductions in AMR genes also did not differ significantly, and adverse events were similar across groups. FMT increased bacterial diversit
- Workflow Redesign Improved Weight Care in Primary Care Trialhttps://reachmd.com/news/workflow-redesign-improved-weight-care-in-primary-care-trial/2486863/Key Takeaways PATHWEIGH was associated with a modest population-level change in weight trajectory during routine primary care. The intervention phase was linked to more discernable weight-related care and larger weight reductions among patients who rec
- Randomized Trial Tests Platelet Rich Plasma for Grade 2 Hamstring Injurieshttps://reachmd.com/news/randomized-trial-tests-platelet-rich-plasma-for-grade-2-hamstring-injuries/2486851/Key Takeaways This randomized trial compared platelet rich plasma with standard therapy alone in grade 2 hamstring muscle injuries. Reported outcome domains included the recovery course, return to play or return to sport, pain-related measures, radiolo
- Incyte Reports Positive Vitiligo Phase 3 Data Supporting JAK Therapieshttps://reachmd.com/news/incyte-reports-positive-vitiligo-phase-3-data-supporting-jak-pipeline/2486888/Incyte provided updated data on two therapies in its dermatology pipeline during its recent earnings call, according to a statement from the company. Ruxolitinib Update
- Intra-Arterial Alteplase After Thrombectomy in Basilar Occlusionhttps://reachmd.com/news/intra-arterial-alteplase-after-thrombectomy-in-basilar-occlusion/2486861/Key Takeaways Adjunct intra-arterial alteplase was not associated with better 90-day functional independence after successful thrombectomy for basilar artery occlusion. Symptomatic intracranial hemorrhage and 90-day mortality were similar between group
- Intrathecal Morphine 75 Mcg vs 100 Mcg for Cesarean Analgesiahttps://reachmd.com/news/intrathecal-morphine-75-mcg-vs-100-mcg-for-cesarean-analgesia/2486862/Key Takeaways The trial compared 75 mcg and 100 mcg intrathecal morphine during spinal anesthesia for cesarean delivery. Analgesic outcomes included postoperative pain, rescue analgesic use, and time to first analgesic request. Common opioid-r
- Multifaceted Strategies for Hypertension Control in Low-Income Patientshttps://reachmd.com/news/multifaceted-strategies-for-hypertension-control-in-low-income-patients/2486840/Key Takeaways The trial reported 18-month changes in systolic blood pressure comparing the intervention and enhanced usual-care groups in low-income adults with hypertension. A low-cost, multifaceted, team-based care strategy—including protocol-based m
- Gut Microbiome May Predict IBS Response to Rifaximin or Low FODMAPhttps://reachmd.com/news/gut-microbiome-may-predict-ibs-response-to-rifaximin-or-low-fodmap/2486829/Key Takeaways Both treatment groups had similar improvement in abdominal pain and bloating at five weeks. Baseline and follow-up stool microbiome profiles differed across low FODMAP responders, rifaximin responders, and non-responders. Breath
- Skill-Based Virtual Reality Therapy Shows Durable Benefit in High-Impact Chronic Painhttps://reachmd.com/news/skill-based-virtual-reality-therapy-shows-durable-benefit-in-high-impact-chronic-pain/2486827/Key Takeaways At 2 years, larger improvements in pain interference, pain intensity, sleep disturbance, and disability were observed in high-impact chronic pain, while depression was not statistically different. At 2 years, 71.1% of participants with hi
- Tucidinostat Plus R-CHOP Improves Outcomes in Double-Expressor DLBCLhttps://reachmd.com/news/tucidinostat-plus-r-chop-improves-outcomes-in-double-expressor-dlbcl/2486836/Key Takeaways Tucidinostat plus R-CHOP was associated with improved event-free survival versus placebo plus R-CHOP in newly diagnosed MYC/BCL2 double-expressor DLBCL. The tucidinostat regimen was also associated with a higher complete response rate at